The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia
Open accessAbstract
Background and Purpose— In animal models of stroke, functional improvement has been obtained after stem cell transplantation. Successful therapy depends largely on achieving a robust and targeted cell engraftment, with intraarterial (IA) injection being a potentially attractive route of administration. We assessed the suitability of laser Doppler flow (LDF) signal measurements and magnetic resonance (MR) imaging for noninvasive dual monitoring of targeted IA cell delivery. Methods— Transient cerebral ischemia was induced in adult Wistar rats (n=25) followed by IA or intravenous (IV) injection of mesenchymal stem cells (MSCs) labeled with superparamagnetic iron oxide. Cell infusion was monitored in real time with transcranial laser Doppler flowmetry while cellular delivery was assessed with MRI in vivo (4.7T) and ex vivo (9.4T). Results— Successful delivery of magnetically labeled MSCs could be readily visualized with MRI after IA but not IV injection. IA stem cell injection during acute stroke resulted in a high variability of cerebral engraftment. The amount of LDF reduction during cell infusion (up to 80%) was found to correlate well with the degree of intracerebral engraftment, with low LDF values being associated with significant morbidity. Conclusions— High cerebral engraftment rates are associated with impeded cerebral blood flow. Noninvasive dual-modality imaging enables monitoring of targeted cell delivery, and through interactive adjustment may improve the safety and efficacy of stem cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Self-citationA double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307
Autologous mesenchymal stem cell transplantation in stroke patients
Bang, O. Y., Lee, J. S., Lee, P. H., & Lee, G. (2005) · Annals of Neurology · doi:10.1002/ana.20501 · Cited by 1,102
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
Bulte, J. W. M., Douglas, T., Witwer, B., Zhang, S.-C., Strable, E., Lewis, B. K., Zywicke, H., Miller, B., van Gelderen, P., Moskowitz, B. M., et al. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1141 · Cited by 1,027
Self-citationKordower, J. H., Freeman, T. B., Snow, B. J., Vingerhoets, F. J. G., Mufson, E. J., Sanberg, P. R., Hauser, R. A., Smith, D. A., Nauert, G. M., Perl, D. P., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321702 · Cited by 860
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants
Bjo¨rklund, A., & Stenevi, U. (1979) · Brain Research · doi:10.1016/0006-8993(79)90472-4 · Cited by 830
Belayev, L., Alonso, O. F., Busto, R., Zhao, W., & Ginsberg, M. D. (1996) · Stroke · doi:10.1161/01.str.27.9.1616 · Cited by 814
Hoehn, M., Küstermann, E., Blunk, J., Wiedermann, D., Trapp, T., Wecker, S., Föcking, M., Arnold, H., Hescheler, J., Fleischmann, B. K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242435499 · Cited by 707
Transplantation of cultured human neuronal cells for patients with stroke
Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J., Jannetta, P., DeCesare, S., Elder, E. M., McGrogan, M., et al. (2000) · Neurology · doi:10.1212/wnl.55.4.565 · Cited by 629
Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction
Kraitchman, D. L., Tatsumi, M., Gilson, W. D., Ishimori, T., Kedziorek, D., Walczak, P., Segars, W. P., H. Chen, H., Fritzges, D., Izbudak, I., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.537480 · Cited by 602
Self-citation
Cited by
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Immunobiology of mesenchymal stem cells
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., & Wang, Y. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.158 · Cited by 771
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
Musiał-Wysocka, A., Kot, M., & Majka, M. (2019) · Cell Transplantation · doi:10.1177/0963689719837897 · Cited by 534
Exosomes — beyond stem cells for restorative therapy in stroke and neurological injury
Zhang, Z. G., Buller, B., & Chopp, M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0126-4 · Cited by 503
Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Becker, A. D., & Riet, I. V. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.73 · Cited by 460
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 433
Mesenchymal Stem Cells Migration Homing and Tracking
Sohni, A., & Verfaillie, C. M. (2013) · Stem Cells International · doi:10.1155/2013/130763 · Cited by 424
Concise Review: MSC Adhesion Cascade—Insights into Homing and Transendothelial Migration
Nitzsche, F., Müller, C., Lukomska, B., Jolkkonen, J., Deten, A., & Boltze, J. (2017) · Stem Cells · doi:10.1002/stem.2614 · Cited by 382
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 367
Is the intravascular administration of mesenchymal stem cells safe?
Furlani, D., Ugurlucan, M., Ong, L., Bieback, K., Pittermann, E., Westien, I., Wang, W., Yerebakan, C., Li, W., Gaebel, R., et al. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.02.001 · Cited by 326
Burgess, A., Ayala-Grosso, C. A., Ganguly, M., Jordão, J. F., Aubert, I., & Hynynen, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027877 · Cited by 282
Nanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275
Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II
Savitz, S. I., Chopp, M., Deans, R., Carmichael, S. T., Phinney, D., & Wechsler, L. (2011) · Stroke · doi:10.1161/strokeaha.110.601914 · Cited by 263
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., Lourhmati, A., Klopfer, T., Schaumann, F., Schmid, B., et al. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1130 · Cited by 261
Magnetic tagging of therapeutic cells for MRI
Budde, M. D., & Frank, J. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053546 · Cited by 78
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Zheng, C., Zhang, J., Chan, H. F., Hu, H., Lv, S., Na, N., Tao, Y., & Li, M. (2021) · Small Methods · doi:10.1002/smtd.202001191 · Cited by 61
Self-citationSchmidtke-Schrezenmeier, G., Urban, M., Musyanovych, A., Mailänder, V., Rojewski, M., Fekete, N., Menard, C., Deak, E., Tarte, K., Rasche, V., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2011.571246 · Cited by 34
Noh, J.-E., Oh, S.-H., Park, I.-H., & Song, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.546659 · Cited by 28
Metadata
- Authors
- Walczak, P., Zhang, J., Gilad, A. A., Kedziorek, D. A., Ruiz-Cabello, J., Young, R. G., Pittenger, M. F., van Zijl, P. C. M., Huang, J., & Bulte, J. W. M.
- Venue
- Stroke
- Published
- 2008-05
- Volume
- 39
- Issue
- 5
- Pages
- 1569-1574
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2120377232
- Cited by
- 405
- References
- 37
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.